These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 32203786

  • 1. Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
    Liu ZY, Tang ML, Ning JF, Hao YP, Zhou L, Sun X.
    Eur J Med Chem; 2020 May 01; 193():112194. PubMed ID: 32203786
    [Abstract] [Full Text] [Related]

  • 2. Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.
    Deng LJ, Wang LH, Peng CK, Li YB, Huang MH, Chen MF, Lei XP, Qi M, Cen Y, Ye WC, Zhang DM, Chen WM.
    J Med Chem; 2017 Jul 13; 60(13):5320-5333. PubMed ID: 28595013
    [Abstract] [Full Text] [Related]

  • 3. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y, Chen X, Ji J, Li L, Zhai G.
    Carbohydr Polym; 2021 Mar 01; 255():117393. PubMed ID: 33436222
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
    Wang J, Xue P, Zhou J, Li L, Xu L, Wang Y.
    Int J Pharm; 2016 May 30; 505(1-2):352-60. PubMed ID: 27085643
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin.
    Deng M, Xue Y, Xu L, Wang Q, Wei J, Ke X, Wang J, Chen X.
    Cell Biochem Funct; 2020 Jan 30; 38(1):47-57. PubMed ID: 31710116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
    Akinboye ES, Rosen MD, Bakare O, Denmeade SR.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6707-6717. PubMed ID: 29153549
    [Abstract] [Full Text] [Related]

  • 12. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.
    Garsky VM, Lumma PK, Feng DM, Wai J, Ramjit HG, Sardana MK, Oliff A, Jones RE, DeFeo-Jones D, Freidinger RM.
    J Med Chem; 2001 Nov 22; 44(24):4216-24. PubMed ID: 11708923
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy.
    Lu X, Fang M, Yang Y, Dai Y, Xu J, Zhao D, Lu Y, Chen X, Lu S, Li N.
    Drug Deliv Transl Res; 2020 Feb 22; 10(1):122-135. PubMed ID: 31444736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.
    Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Ber AP, Petrov SA, Shafikov RR, Skvortsov DA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Ivanenkov YA, Khudyakov AD, Kovalev SV, Erofeev AS, Gorelkin PV, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG.
    Eur J Med Chem; 2022 Jan 05; 227():113936. PubMed ID: 34717125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.